R. Brunet

925 total citations
30 papers, 727 citations indexed

About

R. Brunet is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, R. Brunet has authored 30 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Pathology and Forensic Medicine. Recurrent topics in R. Brunet's work include Cancer Treatment and Pharmacology (9 papers), Colorectal Cancer Treatments and Studies (8 papers) and Lymphoma Diagnosis and Treatment (6 papers). R. Brunet is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Colorectal Cancer Treatments and Studies (8 papers) and Lymphoma Diagnosis and Treatment (6 papers). R. Brunet collaborates with scholars based in France, United States and United Kingdom. R. Brunet's co-authors include Y. Bécouarn, Jean‐Yves Douillard, Marianne Fonck, Esteban Cvitkovic, Éric François, Christophe Louvet, Jean‐Marie Tigaud, Damien Levoir, Philippe Rougier and Aimery de Gramont and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Cancer Immunology Immunotherapy.

In The Last Decade

R. Brunet

28 papers receiving 685 citations

Peers

R. Brunet

ONCOL

PRM

SURGE

HEPAT

Véronique Guerin‐Meyer France

S Nasca France

Seung‐Hoon Beom South Korea

Ayumu Hosokawa Japan

Hajime Yokomizo Japan

Alan Litwin United States

Takayuki Morita Japan

Atsushi Takeshita Japan

Jaroslav P. Stulc United States

Giovanni Pietro Ianniello Italy

Véronique Guerin‐Meyer France

R. Brunet

662 ×1.4

ONCOL

309 ×1.1

PRM

177 ×0.7

SURGE

117 ×1.0

55 ×0.6

HEPAT

Citations per year, relative to R. Brunet R. Brunet (= 1×) peers Véronique Guerin‐Meyer

Countries citing papers authored by R. Brunet

Since Specialization

Citations

This map shows the geographic impact of R. Brunet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Brunet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Brunet more than expected).

Fields of papers citing papers by R. Brunet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Brunet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Brunet. The network helps show where R. Brunet may publish in the future.

Co-authorship network of co-authors of R. Brunet

This figure shows the co-authorship network connecting the top 25 collaborators of R. Brunet. A scholar is included among the top collaborators of R. Brunet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Brunet. R. Brunet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leblanc, F., Marianne Fonck, R. Brunet, et al.. (2007). Comparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastases. European Journal of Surgical Oncology. 34(2). 185–190. 35 indexed citations

Smith, D. M., R. Brunet, Xavier Adhoute, et al.. (2006). Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in second and third-line treatment of metastatic colorectal cancer (mCRC): Safety and efficacy analysis. Journal of Clinical Oncology. 24(18_suppl). 3558–3558. 3 indexed citations

Khayat, David, Olivier Rixe, R. Brunet, et al.. (2004). Pharmacokinetic linearity of i.v. vinorelbine from an intra-patient dose escalation study design. Cancer Chemotherapy and Pharmacology. 54(3). 193–205. 23 indexed citations

Évrard, Serge, Y. Bécouarn, Marianne Fonck, et al.. (2004). Surgical treatment of liver metastases by radiofrequency ablation, resection, or in combination. European Journal of Surgical Oncology. 30(4). 399–406. 52 indexed citations

Fonck, Marianne, et al.. (1998). Dacarbazine, Fluorouracil, and Leucovorin in Patients With Advanced Neuroendocrine Tumors. American Journal of Clinical Oncology. 21(3). 237–240. 33 indexed citations

Canal, Pierre, Caryl Gay, Jean‐Yves Douillard, et al.. (1996). Pharmacokinetics and pharmacodynamics of irinotecan during a phase II clinical trial in colorectal cancer. Pharmacology and Molecular Mechanisms Group of the European Organization for Research and Treatment of Cancer.. Journal of Clinical Oncology. 14(10). 2688–2695. 98 indexed citations

Bécouarn, Y., et al.. (1996). [Immunotherapy of colorectal cancers].. PubMed. 20(1). 20–32. 2 indexed citations

Ruff, Paul, W. Paska, L. Goedhals, et al.. (1994). Ondansetron Compared with Granisetron in the Prophylaxis of Cisplatin-lnduced Acute Emesis: A Multicentre Double-Blind, Randomised, Parallel-Group Study. Oncology. 51(1). 113–118. 90 indexed citations

Ellie, Emmanuel, et al.. (1993). [Paraneoplastic cerebral venous thrombosis].. PubMed. 149(4). 297–9. 7 indexed citations

10.

Stöckle, E, E Bussières, M Stöckle, et al.. (1993). [Is there a place for 2nd look laparotomy in the treatment of ovarian cancers?].. PubMed. 80(7). 629–38. 2 indexed citations

11.

Bécouarn, Y., et al.. (1992). [Systemic chemotherapy in metastatic colorectal adenocarcinomas].. PubMed. 16(2). 166–76. 6 indexed citations

12.

Bécouarn, Y., et al.. (1991). [Modification of taste in cancer patients].. PubMed. 78(10). 901–13. 1 indexed citations

13.

Bui, Binh, et al.. (1991). Cancer chemotherapy in the elderly: a series of 51 patients aged>70 years. Cancer Chemotherapy and Pharmacology. 29(2). 159–163. 16 indexed citations

14.

Bécouarn, Y., et al.. (1989). Fluorouracil, doxorubicin, cisplatin and altretamine in the treatment of metastatic carcinoma of unknown primary. European Journal of Cancer and Clinical Oncology. 25(5). 861–865. 29 indexed citations

15.

Pigneux, J, et al.. (1988). Our experience of conservative treatment of anal canal carcinoma combining external irradiation and interstitial implant: 32 cases treated between 1973 and 1982. International Journal of Radiation Oncology*Biology*Physics. 14(2). 253–259. 24 indexed citations

16.

Bécouarn, Y., et al.. (1987). [Treatment of soft tissue sarcomas in the adult with a combination of vindesine and cisplatin with doxorubicin or epirubicin: a pilot study].. PubMed. 74(2). 109–16. 1 indexed citations

17.

Brunet, R., et al.. (1982). Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer.. PubMed. 66(7). 1563–5. 13 indexed citations

18.

Durand, M., J Chauvergne, Pierre Richaud, et al.. (1978). Chimiothérapie d'induction des lymphomes malins non hodgkiniens. Résultats d'un essai contrôlé comparant deux quadruples associations.. Acta Haematologica. 59(2). 1 indexed citations

19.

Chauvergne, J, et al.. (1977). Induction chemotherapy of non-Hodgkin's malignant lymphomas. European Journal of Cancer (1965). 13(4-5). 399–400. 8 indexed citations

20.

Lagarde, C, et al.. (1976). Traitement des stades cliniques I et II de maladie de Hodgkin. Acta Haematologica. 55(5). 257–264. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact